ALFA News
Straight from the exchange filing
Every announcement Novartis India has filed with the exchanges that we have reported, newest first. Each story links the original filing.
Every Novartis India announcement on ALFA FilingsSee filings →Reference market data from a third-party provider, as of the most recent story. Not a valuation or a recommendation.
Evonile Pharma Limited, formerly Novartis India, approves raising up to ₹900 crore via a rights issue of partly paid-up equity shares to eligible shareholders.
Novartis India enters a ₹10 crore exclusive distribution deal with NHPL for the retina portfolio, marking its entry into India's ophthalmology therapy area.
